Literature DB >> 15729487

A side effect of neuraminidase inhibitor in a patient with liver cirrhosis.

Masahide Kaji1, Takaaki Fukuda, Masatoshi Tanaka, Hisamichi Aizawa.   

Abstract

Neuraminidase inhibitors have been widely used in Japan since 2001, and several side-effects of their use have been reported. However, erythema toxicum has rarely been described as a side-effect of these drugs in patients with liver function disorder. Here, we report a case of generalized rash after treatment with the neuraminidase inhibitors zanamivir and oseltamivir administered prophylactically to prevent influenza infection in two patients with hepatoma associated with liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729487     DOI: 10.1007/s10156-004-0358-7

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir.

Authors:  Miki Hiasa; Yumiko Isoda; Yasushi Kishimoto; Kenta Saitoh; Yasuaki Kimura; Motomu Kanai; Masakatsu Shibasaki; Dai Hatakeyama; Yutaka Kirino; Takashi Kuzuhara
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

2.  In vitro Anti-viral Activity of Psoraleae Semen Water Extract against Influenza A Viruses.

Authors:  Jang-Gi Choi; Young-Hee Jin; Ji-Hye Kim; Tae Woo Oh; Nam-Hui Yim; Won-Kyung Cho; Jin Yeul Ma
Journal:  Front Pharmacol       Date:  2016-11-30       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.